Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13251ExperimentalSmall molecule
Octopamine is structurally similar to norepinephrine. It has been used as a nootropic, and therefore it and all of its enantiomer are prohibited by the World Anti-doping Agency (WADA) as...
- Formula / weight
- C8H11NO2 · 153.1784 g/mol (avg)
Resolves to
Clinical / RWD
Structure
InChIKey
QHGUCRYDKWKLMG-UHFFFAOYSA-NSMILESNCC(O)C1=CC=C(O)C=C1Targets
What you can answer from here — as of January 29, 2025
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Octopamine, and which of those have an active Phase 3 trial?